Quest Diagnostics News
- Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years -Read More
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancerRead More
Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New EnglandRead More
ExamOne Acquires Assets from OptumInsight 10-27-2014
October 27, 2014
LENEXA, KS, October 27, 2014 / -- ExamOne, a Quest Diagnostics company and leader in helping insurers meet their underwriting needs, is pleased to announce the acquisition of certain proprietary assets from OptumInsight that support the ability to provide rapid responses to data inquiries for use in life and health risk assessments. The acquired assets will streamline and improve the ScriptCheck® service offered through ExamOne.
MedPoint is one of the industry’s leading prescription tools that aggregates and organizes pharmacy claims and eligibility records into health profiles to support life and health insurance risk assessment and medical underwriting. It is integrated with up-to-date prescriber and pharmacy details along with market leading analytics. The development of an efficient channel to obtain this data helps the underwriting and risk assessment process by adding additional value and allowing for a more informed decision to be made by the insurer.
“We have a strong commitment to the insurance industry,” said Troy Hartman, President of ExamOne. “The solutions we provide make the underwriting process more convenient for insurance company home office personnel, agents and applicants. There are 95 million uninsured Americans and we are making great strides in efficiency and improving the experience when applicants apply for life insurance. The enhancements we can bring to the market with this acquisition complement the other solutions we provide to our clients and applicants and will aid in a more simplified underwriting process.”
Along with ExamOne’s expansive suite of insurance services (also known as Policy Express) the acquired technology is designed to accelerate the underwriting process, improve risk assessment, assess the accuracy of health statements and discover undisclosed doctors or medical conditions for underwriters.
ExamOne provides the most robust data information to our clients and is proud to offer the life insurance industry the most extensive access to prescription history through ScriptCheck.
As part of the acquisition, the entire team supporting this OptumInsight product will immediately transition over to ExamOne.
ExamOne has provided a portfolio of services to the insurance industry since 1972. It has grown significantly through continuous innovation that meets the evolving needs of life, health and disability insurance providers and their customers. Laboratory testing was part of the company’s original services, which over time have expanded to include paramedical examinations, fraud detection, electronic data collection, and gathering attending physician statements and motor vehicle records. ExamOne also has expanded into helping individuals learn about their own health through its Inside Look™ product. (examone.com/our-solutions/inside-look)
Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operationsRead More